MC
GILD icon

Montag & Caldwell’s Gilead Sciences GILD Stock Holding History

Montag & Caldwell’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-645,811
Closed -$53.9M – 95
2016
Q2 		$53.9M Sell
645,811
-464,164
-42% -$41.2M 1.1% 35
2016
Q1 		$102M Sell
1,109,975
-254,447
-19% -$22.9M 1.87% 30
2015
Q4 		$138M Sell
1,364,422
-614,151
-31% -$63.9M 2.55% 21
2015
Q3 		$194M Sell
1,978,573
-197,024
-9% -$21.9M 3.23% 13
2015
Q2 		$255M Sell
2,175,597
-1,137,871
-34% -$124M 3.62% 7
2015
Q1 		$325M Sell
3,313,468
-382,624
-10% -$38.9M 3.95% 6
2014
Q4 		$348M Sell
3,696,092
-942,387
-20% -$97.5M 3.82% 5
2014
Q3 		$494M Sell
4,638,479
-1,076,480
-19% -$105M 5.13% 1
2014
Q2 		$474M Sell
5,714,959
-320,615
-5% -$25M 4.25% 2
2014
Q1 		$428M Sell
6,035,574
-858,916
-12% -$67.4M 3.74% 6
2013
Q4 		$518M Buy
6,894,490
+3,050,158
+79% +$212M 3.87% 2
2013
Q3 		$242M Buy
+3,844,332
New +$230M 1.82% 32

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Montag & Caldwell's GILD Position: Q3 2016 in Review

Montag & Caldwell sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 645,811 shares — an estimated $53.9M sold.

Montag & Caldwell first reported a position in GILD in Q3 2013 and held it in 12 quarters. The position peaked at $518M in Q4 2013. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Montag & Caldwell reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Montag & Caldwell sold 645,811 Gilead Sciences shares in Q3 2016, an estimated $53.9M.
  • Montag & Caldwell first reported a position in Gilead Sciences in Q3 2013 and held it in 12 quarters.
  • Montag & Caldwell's Gilead Sciences position peaked at $518M in Q4 2013.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Montag & Caldwell's 13F filing for Q3 2016, filed 7 Nov 2016.